Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.42−0.85 (-16.13%)
Close on Nov 16, 2026Market cap $287.45MP/E –Yield –
Treace Medical Concepts profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Treace Medical Concepts's profit margin for the twelve months ending Jun 30, 2026 was -29.0%. For fiscal 2025 it was -27.7%, against -26.6% the year before. The highest annual figure on record is -6.4% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -27.7% | −1.1 |
| FY2024 | Dec 31, 2024 | -26.6% | −0.2 |
| FY2023 | Dec 31, 2023 | -26.5% | +3.7 |
| FY2022 | Dec 31, 2022 | -30.2% | −8.4 |
| FY2021 | Dec 31, 2021 | -21.8% | −15.4 |
| FY2020 | Dec 31, 2020 | -6.4% | +4.4 |
| FY2019 | Dec 31, 2019 | -10.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -35.0% | +1.7 |
| Q1 FY2026 | Mar 31, 2026 | -38.1% | −7.8 |
| Q4 FY2025 | Dec 31, 2025 | -15.0% | −14.3 |
| Q3 FY2025 | Sep 30, 2025 | -32.4% | +1.6 |
| Q2 FY2025 | Jun 30, 2025 | -36.7% | +11.0 |
| Q1 FY2025 | Mar 31, 2025 | -30.3% | +6.3 |
| Q4 FY2024 | Dec 31, 2024 | -0.7% | +9.4 |
| Q3 FY2024 | Sep 30, 2024 | -34.1% | +8.9 |
| Q2 FY2024 | Jun 30, 2024 | -47.7% | −18.5 |
| Q1 FY2024 | Mar 31, 2024 | -36.5% | −4.7 |
| Q4 FY2023 | Dec 31, 2023 | -10.1% | −1.2 |
| Q3 FY2023 | Sep 30, 2023 | -43.0% | −6.3 |
| Q2 FY2023 | Jun 30, 2023 | -29.2% | +28.3 |
| Q1 FY2023 | Mar 31, 2023 | -31.9% | −0.8 |
| Q4 FY2022 | Dec 31, 2022 | -8.9% | +10.9 |
| Q3 FY2022 | Sep 30, 2022 | -36.7% | −7.0 |
| Q2 FY2022 | Jun 30, 2022 | -57.5% | −32.9 |
| Q1 FY2022 | Mar 31, 2022 | -31.1% | −18.1 |
| Q4 FY2021 | Dec 31, 2021 | -19.8% | −30.4 |
| Q3 FY2021 | Sep 30, 2021 | -29.7% | −11.1 |
| Q2 FY2021 | Jun 30, 2021 | -24.6% | +0.9 |
| Q1 FY2021 | Mar 31, 2021 | -13.0% | +1.3 |
| Q4 FY2020 | Dec 31, 2020 | 10.6% | – |
| Q3 FY2020 | Sep 30, 2020 | -18.6% | – |
| Q2 FY2020 | Jun 30, 2020 | -25.5% | – |
| Q1 FY2020 | Mar 31, 2020 | -14.3% | – |
See a number that looks wrong?